Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

BeiGene CEO John Oyler On Investing In Biotech In China: An Interview With PharmAsia News (Part 2 of 2)

Mar 17 2014

• By Tamra Sami

Related Content

Merck Invests In China Oncology Start-up BeiGene

May 02 2011

Merck Serono Opens Bioanalysis Center In Beijing To Support Clinical Trials In Asia; Plans To Double Staff

Sep 21 2011

As Management Talent Moves To China Startups, Will Industry See More In-Licensing Deals?

Oct 25 2011

PPD Continues High-speed Expansion In Asia With Second Acquisition Of A China-based CRO This Quarter

Nov 20 2009

Related Companies

Merck KGaA

Pharmaron Beijing Ltd. Co.

Johnson & Johnson

Merck & Co., Inc.

WuXi AppTec

Beta Pharma, Inc.

Epitomics Inc.

Pharmaron Beijing Ltd. Co.

Revance Inc.

BioMarin Pharmaceutical Inc.

IQVIA Holdings Inc.

Teva Pharmaceutical Industries Ltd.

Genentech, Inc.

Amgen, Inc.

Bristol Myers Squibb Company

Additional Topics

China Asia Pacific Deals Emerging Markets Clinical Trials Business Strategies BioPharmaceutical

More from China

More from Focus On Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window